Press Releases News Category CompanyFinancialGeneralProductScience Year None202320222021 Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise Tax Feb 01, 2023 Read More Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers Jan 30, 2023 Read More Ocean Biomedical Provides Corporate Update and Company Summary Jan 24, 2023 Read More Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc. Jan 13, 2023 Read More Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination Dec 16, 2022 Read More Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination Dec 12, 2022 Read More Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs. Nov 01, 2022 Read More Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 Million Oct 05, 2022 Read More Building on Their Innovative mRNA Vaccine Program, Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) Recently Announced Business Combination to Support the Discovery of a New Class of Antimalarial Drugs. Sep 22, 2022 Read More Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination Sep 19, 2022 Read More First page « Previous page ‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Next page › Last page » Displaying 41 - 50 of 57
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Measures regarding Excise Tax Feb 01, 2023 Read More
Ocean Biomedical and Aesther Healthcare Acquisition Corp. Announce Publication of Discovery Data for a Major Anti-Tumor Pathway in Malignant Melanoma and Other Cancers Jan 30, 2023 Read More
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) Announces Filing of Definitive Proxy Statement with SEC in Connection with its Proposed Business Combination with Ocean Biomedical, Inc. Jan 13, 2023 Read More
Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination Dec 16, 2022 Read More
Aesther Healthcare Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination Dec 12, 2022 Read More
Novel Malaria Drug Discovery Presented at the ASTMH Tropical Medicine Meeting by Ocean Biomedical’s Scientific Co-founder, Dr. Jake Kurtis, unveiling the potential for a new class of Antimalarial Drugs. Nov 01, 2022 Read More
Aesther Healthcare Acquisition Corp (NASDAQ: AEHA) and Ocean Biomedical, Inc. Announce Execution of a Second up to $40 Million Backstop Agreement, for a Total of up to $80 Million Oct 05, 2022 Read More
Building on Their Innovative mRNA Vaccine Program, Ocean Biomedical, Inc. and Aesther Healthcare Acquisition Corp. (NASDAQ: AEHA) Recently Announced Business Combination to Support the Discovery of a New Class of Antimalarial Drugs. Sep 22, 2022 Read More
Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination Sep 19, 2022 Read More
